SCHEMBL30909340

SCHEMBL30909340

O=CNc1ccc2cc(C(=O)O)[nH]c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.51
KDM4E B2RXH2 3/20 0.51
HPGD P15428 3/20 0.51
DAO P14920 2/20 0.51
MAPT P10636 1/20 0.51
SRD5A2 P31213 1/20 0.51
EIF4A3 P38919 2/20 0.51
GPR35 Q9HC97 1/20 0.47
SMAD3 P84022 1/20 0.45
TBXAS1 P24557 1/20 0.44
LMNA P02545 3/20 0.44
ALDH1A1 P00352 3/20 0.44
F7 P08709 1/20 0.44
F3 P13726 1/20 0.44
PIN1 Q13526 1/20 0.44
PDPK1 O15530 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
APEX1 P27695 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30909341 1.00 HSD17B10 (0.51) HSD17B10KDM4EHPGDDAOMAPT
SCHEMBL23486563 0.88 SMAD3 (0.57) HSD17B10KDM4EHPGDDAOMAPT
SCHEMBL28578488 0.81 KDM4E (0.54) HSD17B10KDM4EHPGDDAOMAPT
SCHEMBL3033200 0.78 EIF4A3 (0.55) HSD17B10KDM4EHPGDDAOMAPT
SCHEMBL29865102 0.78 EIF4A3 (0.55) HSD17B10KDM4EHPGDDAOMAPT
SCHEMBL3633240 0.77 EIF4A3 (0.54) HSD17B10KDM4EHPGDDAOMAPT
SCHEMBL5261401 0.76 MMP2 (0.54) HSD17B10KDM4EHPGDDAOMAPT
SCHEMBL8985786 0.76 HSD17B10 (0.56) HSD17B10KDM4EHPGDDAOMAPT
SCHEMBL20761803 0.76 FLT3 (0.57) DAO
SCHEMBL3636947 0.75 MAPT (0.52) HSD17B10KDM4EHPGDDAOMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117959290-B Application of N-benzyl-5/6-formylamino indole-2-carboxylic acid derivative in preparation of medicine for preventing and treating polycystic ovary syndrome 广州医科大学 2025-04-18 CN claimed
CN-117959290-B Application of N-benzyl-5/6-formylamino indole-2-carboxylic acid derivative in preparation of medicine for preventing and treating polycystic ovary syndrome 广州医科大学 2025-04-18 CN disclosed
CN-117959290-B Application of N-benzyl-5/6-formylamino indole-2-carboxylic acid derivative in preparation of medicine for preventing and treating polycystic ovary syndrome 广州医科大学 2025-04-18 CN disclosed
CN-117959290-B Application of N-benzyl-5/6-formylamino indole-2-carboxylic acid derivative in preparation of medicine for preventing and treating polycystic ovary syndrome 广州医科大学 2025-04-18 CN disclosed
CN-117959290-A Application of N-benzyl-5/6-formylamino indole-2-carboxylic acid derivative in preparation of medicine for preventing and treating polycystic ovary syndrome 广州医科大学 2024-05-03 CN disclosed
CN-117959290-A Application of N-benzyl-5/6-formylamino indole-2-carboxylic acid derivative in preparation of medicine for preventing and treating polycystic ovary syndrome 广州医科大学 2024-05-03 CN disclosed
CN-117959290-A Application of N-benzyl-5/6-formylamino indole-2-carboxylic acid derivative in preparation of medicine for preventing and treating polycystic ovary syndrome 广州医科大学 2024-05-03 CN disclosed